CC
Publications
123
Views
62,388
Downloads
16,951
Supervised works
7
Items per page
1 - 123 of 123
Title Published in Access level OA Policy Year Views Downloads
Extrafollicular CD19lowCXCR5CD11c double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosusJournal of translational autoimmunity
accessLevelPublic
2024 84 40
IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermisRheumatology
accessLevelRestricted
2022 289 5
Urinary incontinence in systemic sclerosis: a prospective multicentre cohort studyRheumatology international
accessLevelPublic
2022 139 47
Dysfunctional keratinocytes increase dermal inflammation in systemic sclerosis. Results from tissue-engineered scleroderma epidermisArthritis and Rheumatology
accessLevelPublic
2021 385 297
Native/citrullinated LL37-specific T-cells help autoantibody production in systemic lupus erythematosusScientific Reports
accessLevelPublic
2020 325 134
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohortRheumatology
accessLevelRestricted
2020 284 0
RB139, RB140, RB141 and RB142 antibodies recognize human citrullinated LL37 by ELISAAntibody Reports
accessLevelPublic
2020 268 151
RB137 recognizes LL37 in neutrophil-extracellular trap-like (NET) structures in systemic lupus erythematosus and rheumatoid arthritis inflamed tissues by immunofluorescence in histological sectionsAntibody reports
accessLevelPublic
2020 164 47
Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markersRheumatology
accessLevelRestricted
2020 315 0
Monoclonal antibodies RB139 and RB142 recognize citrullinated LL37 by immunofluorescence in histological sections in Systemic lupus erythematosus (SLE) and Rheumatoid arthritis (RA)Antibody reports
accessLevelPublic
2020 173 48
IL-17A Dissociates Inflammation from Fibrogenesis in Systemic SclerosisJournal of Investigative Dermatology
accessLevelRestricted
2020 363 2
RB137 and RB138 antibodies recognize human cathelicidin LL37 by ELISAAntibody Reports
accessLevelPublic
2020 342 125
Quand penser à une myosite et quelle attitude adopter ?Revue médicale suisse
accessLevelPublic
2019 358 365
Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritisBMC Nephrology
accessLevelPublic
2019 328 140
Molecular characterization of monocyte subsets reveals specific and distinctive molecular signatures associated with cardiovascular disease in rheumatoid arthritisFrontiers in Immunology
accessLevelPublic
2019 340 189
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort studyAnnals of the Rheumatic Diseases
accessLevelRestricted
2019 278 0
Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: a review of the literatureJournal of the American Academy of Dermatology
accessLevelPublic
2019 379 659
Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosusRheumatology
accessLevelPublic
2019 450 210
Anti-C1q antibodies as occurring in systemic lupus erythematosus could be induced by an epstein-barr virus-derived antigenic siteFrontiers in Immunology
accessLevelPublic
2019 268 192
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohortAnnals of the Rheumatic Diseases
accessLevelPublic
2019 340 148
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosisNature Communications
accessLevelPublic
2019 436 213
Phenotypes determined by cluster analysis and their survival in the prospective european scleroderma trials and research cohort of patients with systemic sclerosisArthritis and Rheumatology
accessLevelPublic
2019 278 225
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysisAnnals of the Rheumatic Diseases
accessLevelPublic
2019 279 112
Racial differences in systemic sclerosis disease presentation: a european scleroderma trials and research group studyRheumatology
accessLevelRestricted
2019 296 0
Limbic encephalitis associated with systemic sclerosisMultiple Sclerosis and Related Disorders
accessLevelRestricted
2018 355 0
Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) databaseClinical and Experimental Rheumatology
accessLevelPublic
2018 313 277
Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1Frontiers in Immunology
accessLevelPublic
2018 497 209
Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosusRheumatology
accessLevelRestricted
2018 374 1
Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre studyArthritis Research and Therapy
accessLevelPublic
2018 373 184
Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosusPLOS ONE
accessLevelPublic
2018 573 318
Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosusRheumatology
accessLevelRestricted
2018 406 1
Allergologie et immunologie cliniqueRevue médicale suisse
accessLevelPublic
2018 539 145
Autoantibodies Against Albumin in Patients With Systemic Lupus ErythematosusFrontiers in Immunology
accessLevelPublic
2018 412 178
Chagas disease and systemic autoimmune diseases among Bolivian patients in SwitzerlandMemórias do Instituto Oswaldo Cruz
accessLevelPublic
2018 576 182
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group StudyArthritis and Rheumatology
accessLevelRestricted
2018 272 0
Successful treatment of refractory lupus nephritis by the sequential use of rituximab and belimumabJoint bone spine
accessLevelRestricted
2017 634 1
Mesenteric inflammatory veno-occlusive disease of the spleen metasynchronous with two arterial thrombotic events in systemic lupus erythematosusLupus
accessLevelRestricted
2017 546 2
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric studyArthritis Care and Research
2017 397 0
Matrix Metalloproteinases (MMPs) and cytokines in rheumatologyMatrix Metalloproteinases in health and disease. Sculpting the human body.
2017 303 0
Is there a role for IL-17 in the pathogenesis of systemic sclerosis?Immunology Letters
accessLevelRestricted
2017 451 1
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre studyRheumatology
accessLevelRestricted
2017 538 0
Case Report: Masquerading Large-vessel Giant Cell ArteritisOptometry and Vision Science
accessLevelRestricted
2017 570 1
Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS)BMC immunology
accessLevelPublic
2017 570 448
Basic mechanisms linking inflammation and fibrosisSystemic Fibroinflammatory Disorders
accessLevelRestricted
2017 325 0
Inflammation and immunityScleroderma: from pathogenesis to comprehensive management
accessLevelRestricted
2017 286 0
Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosusNephrology, Dialysis, Transplantation
accessLevelRestricted
2017 501 0
Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of lifeQuality of life research
accessLevelRestricted
2017 509 1
Mapping and predicting mortality from systemic sclerosisAnnals of the Rheumatic Diseases
accessLevelRestricted
2017 382 1
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey)Rheumatology International
accessLevelRestricted
2017 398 0
Keratinocyte-derived IL-17E contributes to inflammation in psoriasisJournal of investigative dermatology
accessLevelRestricted
2016 643 13
A 28-Year-Old Man Presenting With Intractable Dry Cough and a History of Ulcerative ColitisChest
accessLevelRestricted
2016 585 2
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective studyAnnals of the rheumatic diseases
accessLevelRestricted
2016 565 2
IL-22 capacitates dermal fibroblast responses to TNF in sclerodermaAnnals of the rheumatic diseases
accessLevelRestricted
2016 680 7
Sequential, Multimodal Treatment of a Refractory Adult-Onset Still's Disease Complicated by Reactive Hemophagocytic LymphohistiocytosisClinical medical reviews and case reports
accessLevelPublic
2016 424 170
Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross-sectional study of two cohortsLupus
2015 525 0
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR databaseAnnals of the rheumatic diseases
accessLevelRestricted
2015 426 1
Diagnostic Dilemma in Sequential Branch Retinal Vein and Artery OcclusionOptometry and vision science
accessLevelRestricted
2015 638 1
Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximabAnnals of hematology
accessLevelRestricted
2015 586 2
The role of the acquired immune response in systemic sclerosisSeminars in immunopathology
accessLevelRestricted
2015 435 0
Manifestations pulmonaires de la sclérodermie systémiqueRevue médicale suisse
accessLevelRestricted
2015 466 0
Vascularites systémiques : nouvelles nomenclature et approches thérapeutiquesRevue médicale suisse
accessLevelRestricted
2014 424 0
Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective studyAnnals of the rheumatic diseases
accessLevelRestricted
2014 408 0
[Renal disease in ANCA-associated vasculitis]Revue médicale suisse
accessLevelRestricted
2014 474 0
High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosisPloS one
accessLevelPublic
2014 694 315
The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in SwitzerlandSchweizerische medizinische Wochenschrift
accessLevelPublic
2014 751 701
Manifestations digestives de la sclérodermieRevue médicale suisse
accessLevelRestricted
2014 421 0
Acquired factor XIII deficiency: a therapeutic challengeThrombosis and haemostasis
accessLevelRestricted
2013 627 0
Maladies auto-immunes neuromusculaires : diagnostic et prise en chargeRevue médicale suisse
accessLevelRestricted
2013 454 0
Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysisLupus
2013 588 0
Acute natural killer cell pneumonia in a patient transplanted with autologous haematopoietic stem cells for systemic sclerosisRheumatology
accessLevelRestricted
2013 611 0
Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblastsArthritis research & therapy
accessLevelPublic
2013 532 316
Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvementArthritis and rheumatism
accessLevelPublic
2013 630 486
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group databaseAnnals of the rheumatic diseases
accessLevelRestricted
2012 585 0
Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosisAnnals of the rheumatic diseases
accessLevelRestricted
2012 674 0
Interleukin-17 expression in neutrophils and Th17 cells in cutaneous T-cell lymphoma associated with neutrophilic infiltrate of the skinBritish journal of dermatology
accessLevelRestricted
2012 635 1
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-upAnnals of the rheumatic diseases
accessLevelRestricted
2012 572 0
Response of mucocutaneous lesions to rituximab in a case of melanoma differentiation antigen 5-related dermatomyositisDermatology
accessLevelRestricted
2012 626 1
Cardiac involvement in Churg-Strauss syndrome mimicking acute coronary syndromeSchweizerische medizinische Wochenschrift
accessLevelRestricted
2012 655 0
T cell abnormalities in systemic sclerosis with a focus on Th17 cellsEuropean cytokine network
accessLevelRestricted
2012 509 0
Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung diseaseArthritis research & therapy
accessLevelPublic
2011 616 211
Hypereosinophilia in patients with multiple sclerosis treated with natalizumabNeurology
accessLevelRestricted
2011 705 0
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesisArthritis and rheumatism
accessLevelRestricted
2011 648 0
In vivo dioxin favors interleukin-22 production by human CD4+ T cells in an aryl hydrocarbon receptor (AhR)-dependent mannerPloS one
accessLevelPublic
2011 664 243
Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesionsRheumatology
accessLevelRestricted
2011 655 1
Late adult onset of Langerhans cell histiocytosis mimicking glioblastoma multiformeJournal of the neurological sciences
accessLevelRestricted
2011 621 0
Le risque cardiovasculaire dans les maladies auto-immunes systémiquesRevue médicale suisse
accessLevelRestricted
2011 577 0
Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi techniqueClinical and Experimental Rheumatology
accessLevelPublic
2011 495 886
Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cellsEuropean Journal of Immunology
accessLevelRestricted
2010 591 0
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJournal of rheumatology
accessLevelRestricted
2010 565 1
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnnals of the rheumatic diseases
accessLevelRestricted
2010 509 1
Allergo-immunologieRevue médicale suisse
accessLevelRestricted
2010 520 0
CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cellsEuropean Journal of Immunology
accessLevelRestricted
2010 655 0
Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblastsArthritis research & therapy
accessLevelPublic
2010 550 1,493
Prostaglandin E2: igniting the fireImmunology and cell biology
accessLevelRestricted
2009 488 0
Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonialsInfection and immunity
accessLevelRestricted
2009 611 0
Synovial tissues concentrate secreted APRILArthritis research & therapy
accessLevelPublic
2009 627 354
In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosisAmerican journal of respiratory cell and molecular biology
accessLevelRestricted
2008 744 1
Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4Arthritis and rheumatism
accessLevelRestricted
2008 644 0
Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansionBlood
accessLevelRestricted
2008 582 0
T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosisCurrent opinion in rheumatology
accessLevelRestricted
2008 578 0
APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosaThe Journal of clinical investigation
accessLevelPublic
2008 648 613
Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosisArthritis and rheumatism
accessLevelPublic
2007 555 373
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseAnnals of the rheumatic diseases
accessLevelPublic
2007 599 387
Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvementEuropean neurology
accessLevelPublic
2007 1,809 486
Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblastsRheumatology
accessLevelPublic
2007 473 237
Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodiesJournal of neurology, neurosurgery and psychiatry
accessLevelPublic
2007 505 453
Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblastsArthritis research & therapy
accessLevelPublic
2006 519 197
Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblastsThe FASEB journal
accessLevelRestricted
2006 592 0
Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathyArchives of neurology
accessLevelPublic
2006 651 479
Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behçet diseaseJournal of neurology, neurosurgery and psychiatry
accessLevelPublic
2005 550 165
Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signalingEuropean Journal of Immunology
accessLevelPublic
2005 644 452
Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signallingCellular and molecular life sciences
accessLevelPublic
2005 540 315
Vascular occlusion in serpiginous choroidopathyBritish journal of ophthalmology
accessLevelPublic
2005 573 114
Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?Arteriosclerosis, thrombosis, and vascular biology
accessLevelPublic
2005 626 709
Nephrogenic fibrosing dermopathy in a renal transplant recipient with tubulointerstitial nephritis and uveitisDermatology
accessLevelRestricted
2004 487 0
Erythema elevatum et diutinum, multiple sclerosis and interferon betaDermatology
accessLevelPublic
2004 597 44
Diagnostic et prise en charge des pathologies rénales de l'enfantRevue médicale de la Suisse romande
accessLevelRestricted
2004 444 1
Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alphaArthritis and rheumatism
accessLevelPublic
2003 1,013 561
Thrombose des sinus veineux cérébraux dans la maladie de Behcet : description d'un cas et revue de la littératureKlinische Monatsblätter für Augenheilkunde
accessLevelRestricted
2003 553 0
Complete remission of pure white cell aplasia associated with thymoma, autoimmune thyroiditis and type 1 diabetesEuropean journal of haematology
accessLevelPublic
2003 671 101
Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosisArthritis and rheumatism
accessLevelPublic
2002 586 404
Anti-GAD antibodies and breast cancer in a patient with stiff-person syndrome: a puzzling associationEuropean neurology
accessLevelPublic
2001 573 352
Usefulness of serum eosinophil cationic protein (ECP) in predicting relapse of Churg and Strauss vasculitisClinical and Experimental Rheumatology
accessLevelRestricted
2000 431 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack